23 January 2025 in Advanced Materials
DNA can be readily amplified through replication, enabling the detection of a single‐target copy. A comparable performance for proteins in immunoassays has yet to be fully assessed. Surface‐plasmon‐resonance (SPR) serves as a probe capable of performing assays at concentrations typically around 10⁻⁹ molar. In this study, plasmonic single‐molecule assays for both proteins and DNA are demonstrated, achieving limits‐of‐detections (LODs) as low as 10⁻ 2 ⁰ molar (1 ± 1 molecule in 0.1 mL), even in human serum, in 1 h. This represents an improvement in typical SPR LODs by eleven orders‐of‐magnitude. The single‐molecule SPR assay is achieved with a millimeter‐wide surface functionalized with a physisorbed biolayer comprising trillions of recognition‐elements (antibodies or protein–probe complexes) which undergo an acidic or alkaline pH‐conditioning. Potentiometric and surface‐probing imaging experiments reveal the phenomenon underlying this extraordinary performance enhancement. The data suggest an unexplored amplification process within the biomaterial, where pH‐conditioning, driving the biolayer in a metastable state, induces a self‐propagating aggregation of partially misfolded proteins, following single‐affinity binding. This process triggers an electrostatic rearrangement, resulting in the displacement of a charge equivalent to 1.5e per 10 2 recognition elements. Such findings open new opportunities for reliable SPR‐based biosensing at the physical detection limits, with promising applications in point‐of‐care plasmonic systems.
21 February 2024 in Faraday Discussions
While a substantial amount of research activity has been conducted in fields related to organic photonics and electronics, including the development of devices such as organic field-effect transistors, organic photovoltaics, and organic light-emitting diodes for applications encompassing organic thermoelectrics, organic batteries, excitonic organic materials for photochemical and optoelectronic applications, and organic thermoelectrics, this perspective review will primarily concentrate on the emerging and rapidly expanding domain of organic bioelectronics and neuromorphics. Here we present the most recent research findings on organic transistors capable of sensing biological biomarkers down at the single-molecule level (i.e., oncoproteins, genomes, etc.) for the early diagnosis of pathological states and to mimic biological synapses, paving the way to neuromorphic applications that surpass the limitations of the traditional von Neumann computing architecture. Both organic bioelectronics and neuromorphics exhibit several challenges but will revolutionize human life, considering the development of artificial synapses to counteract neurodegenerative disorders and the development of ultrasensitive biosensors for the early diagnosis of cancer to prevent its development. Moreover, organic bioelectronics for sensing applications have also triggered the development of several wearable, flexible and stretchable biodevices for continuous biomarker monitoring.